Relaxin and the Insulin Tango in a 42-Year-Old Man with Metabolic Syndrome

Case Study:  Introduction: This case study examines the interplay between relaxin and insulin in a 42-year-old male patient diagnosed with metabolic syndrome. Metabolic syndrome is a cluster of conditions that increase the risk of cardiovascular disease, diabetes, and other chronic health issues. Relaxin, a hormone previously associated with childbirth, has recently emerged as a potential … Continue reading Relaxin and the Insulin Tango in a 42-Year-Old Man with Metabolic Syndrome